Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Acute phase proteins as biological markers of negative psychopathology in paranoid schizophrenia.

Morera AL, Henry M, García-Hernández A, Fernández-López L.

Actas Esp Psiquiatr. 2007 Jul-Aug;35(4):249-52.

PMID:
17592787
2.

Reliability and validity of the Chinese version of the Calgary Depression Scale for Schizophrenia.

Xiao W, Liu H, Zhang H, Liu Q, Fu P, Chen J, Wang X, Wang G, Li L, Shu L.

Aust N Z J Psychiatry. 2009 Jun;43(6):548-53. doi: 10.1080/00048670902873672.

PMID:
19440887
3.

Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.

Fan X, Pristach C, Liu EY, Freudenreich O, Henderson DC, Goff DC.

Psychiatry Res. 2007 Jan 15;149(1-3):267-71. Epub 2006 Nov 16.

PMID:
17112596
4.

[Depressive symptoms in active phase of paranoid schizophrenia. Part II: Their link to positive symptoms].

Grzywa A, Karakuła H.

Psychiatr Pol. 1998 Jan-Feb;32(1):25-36. Polish.

PMID:
9594581
5.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
6.

Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia.

Angelopoulos EK, Markianos M, Daskalopoulou EG, Hatzimanolis J, Tzemos J.

Psychiatry Res. 2002 May 15;110(1):9-17.

PMID:
12007589
7.
8.

A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE.

Steiner J, Walter M, Wunderlich MT, Bernstein HG, Panteli B, Brauner M, Jacobs R, Gos T, Rothermundt M, Bogerts B.

Biol Psychiatry. 2009 Jun 15;65(12):1107-10. doi: 10.1016/j.biopsych.2008.10.044. Epub 2008 Dec 21.

PMID:
19103440
9.

Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.

Rodriguez-Jimenez R, Aragües M, Jimenez-Arriero MA, Ponce G, Martinez I, Hoenicka J, Rubio G, Palomo T; Psychosis and Addictions Research Group (PARG).

Psychopathology. 2008;41(1):58-64. Epub 2007 Nov 1.

PMID:
17975329
10.

Altered levels of acute phase proteins in the plasma of patients with schizophrenia.

Yang Y, Wan C, Li H, Zhu H, La Y, Xi Z, Chen Y, Jiang L, Feng G, He L.

Anal Chem. 2006 Jun 1;78(11):3571-6.

PMID:
16737209
11.

[Active and prodromal phase symptomatology of young-onset and late-onset paranoid schizophrenia].

Skokou M, Katrivanou A, Andriopoulos I, Gourzis P.

Rev Psiquiatr Salud Ment. 2012 Jul-Sep;5(3):150-9. doi: 10.1016/j.rpsm.2012.03.002. Epub 2012 May 22. Spanish.

12.

Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1879-83. doi: 10.1016/j.pnpbp.2008.08.020. Epub 2008 Sep 4.

PMID:
18801405
13.

Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.

Jäger M, Riedel M, Schmauss M, Pfeiffer H, Laux G, Naber D, Gaebel W, Huff W, Schmidt LG, Heuser I, Buchkremer G, Kühn KU, Rüther E, Hoff P, Gastpar M, Bottlender R, Strauss A, Möller HJ.

Psychiatry Res. 2008 Apr 15;158(3):297-305. doi: 10.1016/j.psychres.2007.01.002. Epub 2008 Feb 15.

PMID:
18280582
14.

Scales for evaluating depressive symptoms in Chinese patients with schizophrenia.

Liu H, Zhang H, Xiao W, Liu Q, Fu P, Chen J, Wang G, Yang F, Wang G, Wang X, Li L.

J Nerv Ment Dis. 2009 Feb;197(2):140-2. doi: 10.1097/NMD.0b013e31819636a5.

PMID:
19214051
15.

A new rating scale for negative symptoms: the Motor-Affective-Social Scale.

Trémeau F, Goggin M, Antonius D, Czobor P, Hill V, Citrome L.

Psychiatry Res. 2008 Sep 30;160(3):346-55. doi: 10.1016/j.psychres.2007.06.021. Epub 2008 Aug 22.

PMID:
18722021
16.

[The factor structure of schizophrenic symptoms: which model is supported by independent item analysis?].

Ozel Kizil ET, Saka MC, Atbaşoğlu EC, Göğüş AK.

Turk Psikiyatri Derg. 2008 Summer;19(2):141-8. Turkish.

17.

The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study.

Lima MS, Soares BG, Paoliello G, Machado Vieira R, Martins CM, Mota Neto JI, Ferrão Y, Schirmer DA, Volpe FM.

Rev Bras Psiquiatr. 2007 Sep;29(3):246-9.

18.

D-serine serum levels in patients with schizophrenia: relation to psychopathology and comparison to healthy subjects.

Hons J, Zirko R, Ulrychova M, Cermakova E, Libiger J.

Neuro Endocrinol Lett. 2008 Aug;29(4):485-92.

PMID:
18766161
19.

Co-morbid social phobia in schizophrenia.

Mazeh D, Bodner E, Weizman R, Delayahu Y, Cholostoy A, Martin T, Barak Y.

Int J Soc Psychiatry. 2009 May;55(3):198-202. doi: 10.1177/0020764008093447.

PMID:
19383663
20.

[Clinico-psychopathologic features and typology of acute paranoid episodes in schizophrenia].

Mukhin AA.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;85(2):236-43. Russian.

PMID:
3984610

Supplemental Content

Support Center